| Articles Reviewed |
| 1: | Anthony J Weinhaus et al. Regulation of glucokinase in pancreatic islets by prolactin: a mechanism for increasing glucose-stimulated insulin secretion during pregnancy. 2007 |
| 2: | F E Utama et al. Human prolactin receptors are insensitive to mouse prolactin: implications for xenotransplant modeling of human breast cancer in mice. 2006 |
| 3: | Mariko Tomita et al. Inhibition of constitutively active Jak-Stat pathway suppresses cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells. 2006 |
| 4: | Sylvia M Major et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. 2006 |
| 5: | Karyn L Butler et al. STAT-3 activation is necessary for ischemic preconditioning in hypertrophied myocardium. 2006 |
| 6: | Shravanti Rampalli et al. Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex. 2005 |
| 7: | Akihiko Numata et al. Signal transducers and activators of transcription 3 augments the transcriptional activity of CCAAT/enhancer-binding protein alpha in granulocyte colony-stimulating factor signaling pathway. 2005 |
| 8: | Masato Moriguchi et al. CXCL12 signaling is independent of Jak2 and Jak3. 2005 |
| 9: | Waltraud X Schulze et al. Phosphotyrosine interactome of the ErbB-receptor kinase family. 2005 |
| 10: | Joao T Barata et al. Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells. 2004 |
| 11: | Yun Dai et al. A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2. 2004 |
| 12: | April N Meyer et al. The cytoplasmic tyrosine kinase Pyk2 as a novel effector of fibroblast growth factor receptor 3 activation. 2004 |
| 13: | Jan Cools et al. The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia. 2004 |
| 14: | Purva Bali et al. Superior activity of the combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 against human acute myelogenous leukemia cells with mutant FLT-3. 2004 |
| 15: | Patricia M-J Lievens et al. The kinase activity of fibroblast growth factor receptor 3 with activation loop mutations affects receptor trafficking and signaling. 2004 |
| 16: | Wei Tong et al. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis. 2004 |
| 17: | Laure Dumoutier et al. Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling. 2004 |
| 18: | Shigeru Akagi et al. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients. 2004 |
| 19: | Feng Zhu et al. Involvement of ERKs and mitogen- and stress-activated protein kinase in UVC-induced phosphorylation of ATF2 in JB6 cells. 2004 |
| 20: | Panos G Ziros et al. Growth hormone attenuates the transcriptional activity of Runx2 by facilitating its physical association with Stat3beta. 2004 |
| 21: | Xiaoyan Jiang et al. Evidence for a positive role of SHIP in the BCR-ABL-mediated transformation of primitive murine hematopoietic cells and in human chronic myeloid leukemia. 2003 |
| 22: | Yosuke Minami et al. Different antiapoptotic pathways between wild-type and mutated FLT3: insights into therapeutic targets in leukemia. 2003 |
| 23: | K C Leung et al. Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2. 2003 |
| 24: | Gregory Riedlinger et al. Bcl-x is not required for maintenance of follicles and corpus luteum in the postnatal mouse ovary. 2002 |
| 25: | Maria Felice Brizzi et al. Diabetic LDL inhibits cell-cycle progression via STAT5B and p21(waf). 2002 |
| 26: | Pipsa Saharinen et al. The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction. 2002 |
| 27: | Diane Lejeune et al. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. 2002 |
| 28: | D Lejeune et al. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling. 2001 |
| 29: | B Sporri et al. JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling. 2001 |
| 30: | K Horsch et al. The protein tyrosine phosphatase-PEST is implicated in the negative regulation of epidermal growth factor on PRL signaling in mammary epithelial cells. 2001 |
| 31: | H Asao et al. Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex. 2001 |
| 32: | D M Stewart et al. Interferon-tau activates multiple signal transducer and activator of transcription proteins and has complex effects on interferon-responsive gene transcription in ovine endometrial epithelial cells. 2001 |
| 33: | F Blanchard et al. Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor alpha, and oncostatin M receptor beta by distinct mechanisms. 2001 |
| 34: | A L Sirén et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. 2001 |